API Pharmaceutical Intermediate Taxol Anti-Tumour CAS 33069-62-4 Taxol Anti-Cancer Effect Taxol

• Customization: Available
• CAS No.: 33069-62-4
• Formula: C47h51no14
• Model NO.: QS-Taxol
• EINECS: 608-826-9
• Packaging Material: Negotiable
• Storage Method: Normal
• Shelf Life: 2 Years
• Nutrient Composition: Taxol
• Resource: Taxol
• Product Name: Taxol
• Name: Taxol Powder
• Appearance: White Powder
• Color: White
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Antibiotic
• Specific: COA
• Test Method: HPLC
• Mf: C47h51no14
• Boiling Point: 957.115ºC at 760 Mmhg
• Melting Point: 213 °c
• Storage Temperature: 2-8 C
• CAS: 33069-62-4
• MW: 853.918
• Transport Package: Negotiable
• Specification: 99%
• Trademark: QS
• Origin: Shaanxi Xi′an
• Production Capacity: 1000kg/Month

Product Description

API Pharmaceutical Intermediate Taxol  Anti-Tumour CAS 33069-62-4 Taxol Anti-Cancer Effect Taxol

Product Description

Product Detials

Product Name	Taxol
Apperance	White to off-white powder
CAS	33069-62-4
MF	C47H51NO14
MW	853.918

Paclitaxel is a diterpenoid compound with a complex chemical structure, featuring a taxane ring that is essential for its biological activity. Due to its poor solubility in water, it is typically formulated with Cremophor EL (polyoxyethylated castor oil) or albumin-bound (nab-paclitaxel, Abraxane®) for clinical administration. The albumin-bound formulation reduces hypersensitivity risks and improves drug delivery.

Application&Function

1.Breast Cancer

Used for metastatic breast cancer and adjuvant therapy.
Nab-paclitaxel (Abraxane®) is preferred due to reduced toxicity.
Often combined with doxorubicin or trastuzumab (Herceptin®).
2.Ovarian Cancer

First-line treatment in combination with carboplatin.
Effective in platinum-resistant recurrent ovarian cancer.
3.Non-Small Cell Lung Cancer (NSCLC)

Used with carboplatin as first-line therapy.
Improves survival in advanced NSCLC.
4.Pancreatic Cancer & Kaposi's Sarcoma

Nab-paclitaxel + gemcitabine for metastatic pancreatic cancer.
Second-line treatment for AIDS-related Kaposi's sarcoma.

Specification

Certificate of Analysis